APA (7th ed.) Citation

Chang, C., Liang, T., & Lam, H. Y. P. (2024). The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production. Biomolecules (2218-273X), 14(1), 74. https://doi.org/10.3390/biom14010074

Chicago Style (17th ed.) Citation

Chang, Chun-Ming, Ting-Ruei Liang, and Ho Yin Pekkle Lam. "The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production." Biomolecules (2218-273X) 14, no. 1 (2024): 74. https://doi.org/10.3390/biom14010074.

MLA (9th ed.) Citation

Chang, Chun-Ming, et al. "The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production." Biomolecules (2218-273X), vol. 14, no. 1, 2024, p. 74, https://doi.org/10.3390/biom14010074.